Moderna, Inc.: Moderna and CytomX Announce Strategic Researc

Collaboration will combine Moderna's mRNA technology with CytomX's Probody® Platform to generate and develop therapeutics for oncology and non-oncology conditionsCytomX to receive $35 million upfront payment

Related Keywords

United States , Cambridge , Cambridgeshire , United Kingdom , Mary Beth Woodin , Lavina Talukdar , Stephanie Ascher , Sean Mccarthy , Chris Ogden , Rose Loughlin , Amgen , Linkedin , Twitter , Company Contact , Cytomx Therapeutics Inc , Nasdaq , Exchange Commission , Early Development , Moderna Inc View , Moderna Inc , Bristol Myers Squibb , Wrd Communications , Cytomx Therapeutics , Senior Vice President , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Probody Platform , Vice President , Media Relations , Inc View , Moderna , Ytomx , Nnounce , Strategic , Research , Collaboration , Rna , Ased , Nconditionally , Activated , Herapeutics ,